Thursday, February 20, 2020

 


Apple Inc
(NASDAQ: AAPL) Add to Watchlist
$319.26
-4.36 (-1.35%)
as of 12:26 EST

Thinking about buying stock in Apple, Axsome Therapeutics, Crocs, Lululemon Athletica, or Tilray?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, AXSM, CROX, LULU, and TLRY.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

-- AAPL: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=AAPL&prnumber=011320200

-- AXSM: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=AXSM&prnumber=011320200

-- CROX: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=CROX&prnumber=011320200

-- LULU: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=LULU&prnumber=011320200

-- TLRY: https://www.investorsobserver.com/pr-stocks-lp/?stocksymbol=TLRY&prnumber=011320200

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

https://c212.net/c/img/favicon.png?sn=CG87662&sd=2020-01-13

View original content:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-apple-axsome-therapeutics-crocs-lululemon-athletica-or-tilray-300985635.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG87662&Transmission_Id=202001130931PR_NEWS_USPR_____CG87662&DateId=20200113

© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.